New cancer clinical trial: Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)

Published on: 2026-10-23T04:00:00Z
Conditions: Respiratory Recurrent Papillomatosis (RRP); Human Papillomavirus (HPV); Papillomavirus Infection; Laryngeal Diseases; Tracheal Diseases; Respiratory Tract Neoplasm
Interventions: Drug: PRGN-2012; Drug: Bevacizumab
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/W8UjbwM Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)